Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-02-02
1996-10-22
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 72, 435 4, G01N 33567, G01N 3353, C12Q 100
Patent
active
055675921
ABSTRACT:
A screening method for the identification of bioenhancers that increase the bioavailability of an orally administered pharmaceutical compound through the inhibition of P-glycoprotein transport activity in the gut of a mammal is disclosed. These compounds increase the systemic availability of a pharmaceutical compound when administered prior to, or concurrently with, that compound.
REFERENCES:
patent: 4693966 (1987-09-01), Houghton et al.
patent: 4822816 (1989-04-01), Markham
patent: 4849227 (1989-07-01), Cho
patent: 4944949 (1990-07-01), Story et al.
patent: 4968716 (1990-11-01), Markham
patent: 5070085 (1991-12-01), Markham
patent: 5332747 (1994-07-01), Van Dyke
patent: 5409690 (1995-04-01), Howell et al.
patent: 5436243 (1995-07-01), Sachs et al.
Hunter, J. et al. "Epithelial Secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein." British Journal of Cancer 64:437-444, 1991.
Arias, I. M. et al. "Structure & function of P-glycoprotein in the normal liver." In: Xenobiotics and Cancer (L. Ernster et al., eds.) Japan Sci. Soc. Press, Tokyo/Taylor & Francis, Ltd, London, 1991, pp. 229-239.
Peters, W. H., et al. "Expression of Drug-Metabolizing Enzymes and p-170 glycoprotein in Colorectal Carcinoma and Normal Mucosa," Gastroenterology 103: 448-455, 1992.
Keller et al., 1992, Int. J. Cancer 51:433-438.
Qian et al., Binding of an Optically Pure Photoaffinity Analogue of Verapamil, LU-49888, to P-Glycoprotein from Multidrug-resistant Human Leukemic Cell Lines, Cancer Research 50:1132-1137, Feb. 15, 1990.
Watkins, 1992, Gastroin. Pharmacol. 21:511-526.
Watkins, 1990, J. Amer. Acad. Dermatol. 23:1301-1311.
Hunter et al., 1991, Br. J. Cancer 64:437-444.
Arias et al., 1991, in Xenobiotics and Cancer (L. Ernster et al., eds.) Japan Sci. Soc. Press, Tokyo, pp. 229-239.
Hsing et al. 1992, Gastroentrol. 102:879-885.
Peters et al., 1992, Gastroenterol. 103:448-455.
Fojo, 1991, Adv. Int. Med. 36:195-218.
Albengres, E., et al., International Journal of Clinical Pharmacology et al., 30/12; 555-570.
Baciewicz, A. M. et al., Archives of Internal Medicine, 153/17; 1970-76.
Back, D. J., et al., British Journal of Clinical Pharmacology, 28; 166-170.
Back, D. J., et al., British Journal of Dermatology, Supplemental; 126; 14-18.
Chan, G. L., et al., Clinical Transplantation, 6/3/1; 141-153.
de Smet, M. D., et al., American Journal of Ophthalmology, 113; 687-690.
First, M. R., et al., The Lancet, 2; 1198-1201.
First, M. R., et al., Transplantation, 51/2; 365-370.
Henricsson, S., et al., Pharmacology & Toxicology, 66; 49-52.
Pichard, L., et al., Drug Metabolism and Disposition, 18/5; 595-606.
Pichard, L., et al., Molecular Pharmacology, 41/6; 1047-1055.
Sands, M., et al., Reviews of Infectious Diseases, 11/1; 691-697.
Sridhar, T. J., et al., Clinical Transplantation, 6/2; 134-138.
Yee, G. C., et al., Clinical Pharmacokinetics, 19/4; 319-332.
Back, David J., and Orme, Michael L'E.; "Pharmacokinetic Drug Interactions with Oral Contraceptives", (1990) Clin. Pharmacokinet. 18(6):472-484.
Callaghan, Richard and Riordan, John R.; "Synthetic and Natural Opiates Interact with P-glycoprotein in Multidrug-resistant Cells", (1993) J. Biol. Chem. 268(21):16059-16064.
Clynes, Martin; "Cellular Models for Multiple Drug Resistance in Cancer", (1993) In Vitro Cell. Dev. Biol. 29A:171-179.
Endicott, Jane A., and Ling, Victor; "The Biochemistry of P-glycoprotein-mediated Multidrug Resistance", (1989) Annu. Rev. Biochem. 58:137-171.
Fahr, Alfred; "Cyclosporin Clinical Pharmacokinetics" (1993) Clin. Pharmacokinetic 24(6):472-495.
Fairchild, Craig R., and Cowan, Kenneth H.; "Keynote Address: Multidrug Resistance: A Pleiotropic Response To Cytotoxic Drugs" (1991) Int. J. Radiation Oncology Biol. Phys. 20:361-367.
Fasco, Michael J. et al.; "Rat Small Intestinal Cytochromes P450 Probed by Warfarin Metabolism" (1993) Mol. Pharmacol. 43:226-233.
Fojo, Antonio T.; "Multidrug Resistance" (1991) Adv. Intern. Med. 36:195-218.
Gatmaitan, Zenaida C. and Arias, Irwin M.; "Structure and Function of P-Glycoprotein in Normal Liver and Small Intestine" (1993) Adv. Pharmacol. 24:77-97.
Greenblatt. David J.; "Presystemic Extraction: Mechanisms and Consequences" (1993) J. Clin. Pharmacol 33:650-656.
Hait, William N. et al.; "Terfenadine (Seldane.RTM.):A New Drug for Restoring Sensitivity to Multidrug Resistant Cancer Cells" (1993) Biochem. Pharmacol 45:401-406.
Hebert, Mary F. et al.; "Bioavailability of Cyclosporine with Concomitant Rifampin Administration is Markedly Less Than Predicted by Hepatic Enzyme Induction" (1992) Clin. Pharmacol. Ther. 52:453-457.
Hsing, Shu et al.; "The Function of Gp170, the Multidrug-Resistance Gene Product. in the Brush Border of Rat Intestinal Mucosa" (1992) Gastroenterology 102:879-885.
Hunter, Janice et al.; "Functional Expression of P-glycoprotein in Apical Membranes of Human Intestinal Caco-2 Cells" (1993) J. Biol. Chem. 268:14991-14997.
Jancis, Erik M. et al.; "Estradiol Induction of Rhodamine 123 Efflux and the Mutidrug Resistance Pump in Rat Pituitary Tumor Cells" (1993) Mol. Pharmachol. 43:51-56.
Kaminsky, Laurence, and Fasco, Michael J.; "Small Intestinal cytochromes P450" (1991) Critical Reviews in Toxicology 21:407-422.
Kolars, Joseph C. et al.; "Identification of Rifampin-inducible P450IIIA4 (CY93A4) in Human Small Bowel Enterocytes" 1992 J. Clin. Invest. 90:1871-1878.
Kolars, Joseph C. et al.; "Heterogeneity fo Cytochrome P450IIIA Expression in Rat Gut Epithelia" (1992) Gastroenterology 102:1186-1198.
Kolars, Joseph C. et al.; "Cyclosporine Metabolism by P450IIIA in Rat Enterocytes--Another Determinant of Oral Bioavailability?" (1992) Transplantation 53:596-602.
Komori, Masayuki et al.; "Cytochrome P-450 in Human Liver Microsomes: High-Performance Liquid Chromatographic Isolation of Three Forms and Their Characterization" (1988) J. Biochem 104:912-916.
Kralovanszky, Judit et al.; "Isolation of Viable Intestinal Epithelial Cell and Their Use for in Vitro Toxicity Studies" (1990) In Vivo 4:201-204.
Kronbach, Thomas et al.; "Cyclosporine Metabolism in Human Liver: Identification of a Cytochrome P450III Gene Family as the Major Cyclosporine-Metabolizing Enzyme Explains Interactions of Cyclosporine With Other Drugs" (1988) Clin. Pharmacol. Ther. 43:630-635.
Kronbach, Thomas et al.; "Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4" (1989) Molec. Pharm. 36:89-96.
Lalka, David et al.; "The Hepatic First-Pass Metabolism of Problematic Drugs" (1993) J. Clin. Pharmacol. 33:657-669.
Ludescher, Christof et al.; "Rapid Functional Assay for the Detection of Multidrug-Resistant Cells Using the Fluorescent Dye Rhodamine 123 (Letter;Comment)" (1991) Blood 78:1385-1387.
Ludescher, Christof et al.; "Detection of Activity of P-Glycoprotein in Human Tumor Samples Using Rhodamine 123" (1992) Br. J. Haematol. 82:161-168.
Lum, Bert L. et al.; "Clinical Trials of Modulation of Multidrug Resistance. Pharmacokinetic and Pharmacodynamic Considerations" (1993) Cancer 72:3502-3514.
Lum, Bert L. et al.; "Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene" (1993) Pharmacotherapy 13:88-109.
Muranishi, Shozo; "Absorbtion Enhancers" (1990) Crit. Rev. Ther. Drug Carrier Sys. 7:1-33.
Nielsen, Dorte et al.; "P-Glycoprotein as Multidrug Transporter: A Critical Review of Current Multidrug Resistant Cell Lines" (1992) Biochim. Biophys. Acta. 1139:169-183.
Pearce, H. L. et al.; "Essential Features of the P-Glycoprotein Pharmacophore as Defined by a Series of Reserpine Analogs That Modulate Multidrug Resistance" (1989) Proc. Natl. Acad. Sci. 86:5128-5132.
Pichard, Lydiane et al.; "Cyclosporine A Drug Interactions: Screening for Inducers and Inhibitors of Cytochrome P-450 (Cyclosporine A Oxidase) in Primary Cultures of Human Hepatocytes and in Liver Microsomes" (1990) Drug. Metab. Dipos. 18:595-606.
Schmiedlin-Ren, Phyllissa et al.; "Cultured Adult Rat Jejunal Explants as a Model for Studying Regulation of CYP3A" (1993) Biochem. Pharmacol. 46:905-918.
Somberg, John et al.; "The Clinical Implications of First-Pass Metabolism: Treatmen
Benet Leslie
Wu Chi Y.
Nucker Christine M.
Parkin Jeffrey S.
Regents of the University of California
LandOfFree
Screening method for the identification of bioenhancers through does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for the identification of bioenhancers through , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for the identification of bioenhancers through will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358016